Viz.ai’s AI algorithm for cardiomyopathy receives FDA approval

By leveraging Viz HCM, which is incorporated into the Viz.ai platform, physicians can identify more individuals with suspected HCM,…

Source: www.medicaldevice-network.com – Read more